Balance Sheet Insights: Amarin Corp ADR (AMRN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Amarin Corp ADR (NASDAQ: AMRN) closed at $0.78 down -2.05% from its previous closing price of $0.80. In other words, the price has decreased by -$2.05 from its previous closing price. On the day, 0.64 million shares were traded. AMRN stock price reached its highest trading level at $0.8044 during the session, while it also had its lowest trading level at $0.7705.

Ratios:

For a deeper understanding of Amarin Corp ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.93 and its Current Ratio is at 3.07. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.

On October 25, 2023, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $3 to $1.

Jefferies Upgraded its Hold to Buy on January 06, 2023, whereas the target price for the stock was revised from $1.30 to $3.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 22 ’24 when Holt Patrick bought 14,426 shares for $1.09 per share. The transaction valued at 15,724 led to the insider holds 314,426 shares of the business.

Ketchum Steven B sold 34,131 shares of AMRN for $26,963 on Dec 12 ’23. The Chief Scientific Officer now owns 566,100 shares after completing the transaction at $0.79 per share. On Aug 16 ’23, another insider, Holt Patrick, who serves as the President and CEO of the company, bought 300,000 shares for $1.04 each. As a result, the insider paid 312,315 and bolstered with 300,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMRN now has a Market Capitalization of 320477792 and an Enterprise Value of 22412554. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.15 while its Price-to-Book (P/B) ratio in mrq is 0.59. Its current Enterprise Value per Revenue stands at 0.081 whereas that against EBITDA is -0.978.

Stock Price History:

Over the past 52 weeks, AMRN has reached a high of $1.37, while it has fallen to a 52-week low of $0.63. The 50-Day Moving Average of the stock is 0.85%, while the 200-Day Moving Average is calculated to be -12.37%.

Shares Statistics:

For the past three months, AMRN has traded an average of 1.48M shares per day and 918530 over the past ten days. A total of 410.74M shares are outstanding, with a floating share count of 409.14M. Insiders hold about 0.39% of the company’s shares, while institutions hold 22.03% stake in the company. Shares short for AMRN as of 1721001600 were 18931154 with a Short Ratio of 12.76, compared to 1718323200 on 19020869. Therefore, it implies a Short% of Shares Outstanding of 18931154 and a Short% of Float of 4.67.

Most Popular